Update on Stock Availability of Trulicity® (dulaglutide) 1.5mg

Update on Stock Availability of Trulicity® (dulaglutide) 1.5mg

Eli Lilly Australia (Lilly) continues to have limited availability of the Type 2 Diabetes (T2D) medication, Trulicity® (dulaglutide) due to global supply pressures resulting from increased demand. As reflected on the TGA Medicine Shortage Reports database(1), this is expected to continue until 31 March 2023.

click here to order Trulicity online without prescription

With limited availability of stock, Lilly anticipates delays, interruptions and/or shortages in stock available through wholesalers and at pharmacies during this time.

Lilly is in frequent contact with wholesalers, and together we are closely monitoring stock levels. We are releasing stock to wholesalers as equitably as possible. We anticipate that patients could experience delays of several weeks in having their prescriptions filled, depending on location and wholesaler.  Lilly does not have visibility of stock on hand at pharmacies.

Healthcare professionals are asked to consider the impact of limited product availability on patients when making treatment choices, particularly for new patient initiations. 

For patients with T2D

We recognise these are challenging circumstances for patients on Trulicity in Australia. It is best to leave your prescription as early as possible with your regular pharmacy to allow your pharmacist time to order your Trulicity.  If you are unable to fill your prescription in time for your next dose, please consult your healthcare professional regarding your treatment plan.  In the instance that you miss a dose of Trulicity, please consult your healthcare professional and refer to the information contained in the Trulicity Consumer Medicine Information.

For prescribers & pharmacists :

Healthcare professionals requiring further medical or scientific information about Trulicity may contact the Lilly Medical Information team on 1800 454 559 /1800 4 LILLY (operating hours Monday to Friday, 9am – 5pm AEST).

Lilly remains committed to future replenishment of the Trulicity supply chain and will publish an update if Trulicity supply status changes.

1. Australian Department of Health, Therapeutic Goods Administration, available at http://apps.tga.gov.au/Prod/msi/search?shortagetype=All, last accessed 14 November 2022

TRULICITY® is a registered trademark of Eli Lilly and Company.

Eli Lilly Australia Pty Limited 112 Wharf Rd, West Ryde NSW 2114, Australia. ABN 39 000 233 922. Prepared November 2022. PP-DG-AU-0932

Leave a Reply

Your email address will not be published. Required fields are marked *